A prospective, non-interventional study in female patients with moderate to severe active rheumatoid arthritis in France receiving filgotinib for 2 years (PARROTFISH)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/49028
• EU PAS number:
  EUPAS46020
• Study ID:
  49028
• Official title and acronym:
  A prospective, non-interventional study in female patients with moderate to severe active rheumatoid arthritis in France receiving filgotinib for 2 years (PARROTFISH)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  To describe the effectiveness, safety, and patient-reported outcomes in female patients with moderate to severe active rheumatoid arthritis in France receiving filgotinib in real-world setting.
• Study status:
  Ongoing

Research institution and networks

Institutions

Galapagos

Study timelines

Date when funding contract was signed

Actual: 30/12/2021

Study start date

Actual: 03/05/2022

Date of final study report

Planned: 30/04/2026

Sources of funding

Other

More details on funding

Galapagos NV

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

ClinicalTrials.gov Identifier: https://clinicaltrials.gov/ct2/show/NCT05323591